Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ditzel

Showing results (191-200 of 314) with videos related to

Pageof 32
Sort By:
Plos One|January 24, 2013
Gene expression signatures that predict outcome of tamoxifen-treated estrogen receptor-positive, high-risk, primary breast cancer patients: a DBCG studyMaria B Lyng, Anne-Vibeke Lænkholm, Qihua Tan, et al.
Molecular Oncology|April 4, 2014
Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control studyAnnette R Kodahl, Maria B Lyng, Harald Binder, et al.
Human Reproduction (Oxford, England)|July 10, 2008
Distinct GAGE and MAGE-A expression during early human development indicate specific roles in lineage differentiationMorten F Gjerstorff, Linda Harkness, Moustapha Kassem, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 15, 2016
From the Cover: Arsenic Induces Accumulation of α-Synuclein: Implications for Synucleinopathies and NeurodegenerationAram B Cholanians, Andy V Phan, Eric J Ditzel, et al.
F1000Research|August 20, 2016
Robust de novo pathway enrichment with KeyPathwayMiner 5Nicolas Alcaraz, Markus List, Martin Dissing-Hansen, et al.
Genes|March 6, 2021
HMGA2 as a Critical Regulator in Cancer DevelopmentBehzad Mansoori, Ali Mohammadi, Henrik J Ditzel, et al.
Oncoimmunology|June 23, 2017
Downregulation of antigen presentation-associated pathway proteins is linked to poor outcome in triple-negative breast cancer patient tumorsMartin H Pedersen, Brian L Hood, Hans Christian Beck, et al.
Breast Cancer Research and Treatment|February 2, 2012
The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancerKarina H Gravgaard, Maria B Lyng, Anne-Vibeke Laenkholm, et al.
The Journal of Experimental Medicine|September 30, 2018
KDM4B-regulated unfolded protein response as a therapeutic vulnerability in <i>PTEN</i>-deficient breast cancerWenyu Wang, Gokce Oguz, Puay Leng Lee, et al.
Oncogene|September 23, 2018
Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapyD Elias, H Vever, A-V Lænkholm, et al.
Pageof 32

Showing results (191-200 of 314) with videos related to

Sort By:
Pageof 32
Plos One|January 24, 2013
Gene expression signatures that predict outcome of tamoxifen-treated estrogen receptor-positive, high-risk, primary breast cancer patients: a DBCG studyMaria B Lyng, Anne-Vibeke Lænkholm, Qihua Tan, et al.
Molecular Oncology|April 4, 2014
Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control studyAnnette R Kodahl, Maria B Lyng, Harald Binder, et al.
Human Reproduction (Oxford, England)|July 10, 2008
Distinct GAGE and MAGE-A expression during early human development indicate specific roles in lineage differentiationMorten F Gjerstorff, Linda Harkness, Moustapha Kassem, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 15, 2016
From the Cover: Arsenic Induces Accumulation of α-Synuclein: Implications for Synucleinopathies and NeurodegenerationAram B Cholanians, Andy V Phan, Eric J Ditzel, et al.
F1000Research|August 20, 2016
Robust de novo pathway enrichment with KeyPathwayMiner 5Nicolas Alcaraz, Markus List, Martin Dissing-Hansen, et al.
Genes|March 6, 2021
HMGA2 as a Critical Regulator in Cancer DevelopmentBehzad Mansoori, Ali Mohammadi, Henrik J Ditzel, et al.
Oncoimmunology|June 23, 2017
Downregulation of antigen presentation-associated pathway proteins is linked to poor outcome in triple-negative breast cancer patient tumorsMartin H Pedersen, Brian L Hood, Hans Christian Beck, et al.
Breast Cancer Research and Treatment|February 2, 2012
The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancerKarina H Gravgaard, Maria B Lyng, Anne-Vibeke Laenkholm, et al.
The Journal of Experimental Medicine|September 30, 2018
KDM4B-regulated unfolded protein response as a therapeutic vulnerability in <i>PTEN</i>-deficient breast cancerWenyu Wang, Gokce Oguz, Puay Leng Lee, et al.
Oncogene|September 23, 2018
Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapyD Elias, H Vever, A-V Lænkholm, et al.
Pageof 32